世界の先端巨大症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acromegaly Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0034 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、先端巨大症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オクトレオチド、パシレオチド、ランレオチド、ペグビソマント）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・先端巨大症治療の市場動向 ・企業の競争状況、市場シェア ・先端巨大症治療の種類別市場規模（オクトレオチド、パシレオチド、ランレオチド、ペグビソマント） ・先端巨大症治療の用途別市場規模（病院、薬局） ・先端巨大症治療の北米市場規模2016-2027（アメリカ、カナダ） ・先端巨大症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・先端巨大症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・先端巨大症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・先端巨大症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、IPSEN、Pfizer） ・結論

Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly.

Market Analysis and Insights: Global Acromegaly Therapeutics Market
The global Acromegaly Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acromegaly Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acromegaly Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acromegaly Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acromegaly Therapeutics market.

Global Acromegaly Therapeutics Scope and Market Size
Acromegaly Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acromegaly Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Octreotide
Pasireotide
Lanreotide
Pegvisomant

Segment by Application
Hospital
Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acromegaly Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Octreotide
1.2.3 Pasireotide
1.2.4 Lanreotide
1.2.5 Pegvisomant
1.3 Market by Application
1.3.1 Global Acromegaly Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acromegaly Therapeutics Market Perspective (2016-2027)
2.2 Acromegaly Therapeutics Growth Trends by Regions
2.2.1 Acromegaly Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acromegaly Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acromegaly Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acromegaly Therapeutics Industry Dynamic
2.3.1 Acromegaly Therapeutics Market Trends
2.3.2 Acromegaly Therapeutics Market Drivers
2.3.3 Acromegaly Therapeutics Market Challenges
2.3.4 Acromegaly Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acromegaly Therapeutics Players by Revenue
3.1.1 Global Top Acromegaly Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acromegaly Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acromegaly Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acromegaly Therapeutics Revenue
3.4 Global Acromegaly Therapeutics Market Concentration Ratio
3.4.1 Global Acromegaly Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Therapeutics Revenue in 2020
3.5 Acromegaly Therapeutics Key Players Head office and Area Served
3.6 Key Players Acromegaly Therapeutics Product Solution and Service
3.7 Date of Enter into Acromegaly Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acromegaly Therapeutics Breakdown Data by Type
4.1 Global Acromegaly Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acromegaly Therapeutics Forecasted Market Size by Type (2022-2027)

5 Acromegaly Therapeutics Breakdown Data by Application
5.1 Global Acromegaly Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acromegaly Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acromegaly Therapeutics Market Size (2016-2027)
6.2 North America Acromegaly Therapeutics Market Size by Type
6.2.1 North America Acromegaly Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acromegaly Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acromegaly Therapeutics Market Size by Type (2016-2027)
6.3 North America Acromegaly Therapeutics Market Size by Application
6.3.1 North America Acromegaly Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acromegaly Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acromegaly Therapeutics Market Size by Application (2016-2027)
6.4 North America Acromegaly Therapeutics Market Size by Country
6.4.1 North America Acromegaly Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acromegaly Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acromegaly Therapeutics Market Size (2016-2027)
7.2 Europe Acromegaly Therapeutics Market Size by Type
7.2.1 Europe Acromegaly Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acromegaly Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acromegaly Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acromegaly Therapeutics Market Size by Application
7.3.1 Europe Acromegaly Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acromegaly Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acromegaly Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acromegaly Therapeutics Market Size by Country
7.4.1 Europe Acromegaly Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acromegaly Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acromegaly Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acromegaly Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acromegaly Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acromegaly Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acromegaly Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acromegaly Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acromegaly Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acromegaly Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acromegaly Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acromegaly Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acromegaly Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acromegaly Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acromegaly Therapeutics Market Size (2016-2027)
9.2 Latin America Acromegaly Therapeutics Market Size by Type
9.2.1 Latin America Acromegaly Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acromegaly Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acromegaly Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acromegaly Therapeutics Market Size by Application
9.3.1 Latin America Acromegaly Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acromegaly Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acromegaly Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acromegaly Therapeutics Market Size by Country
9.4.1 Latin America Acromegaly Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acromegaly Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acromegaly Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acromegaly Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acromegaly Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acromegaly Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acromegaly Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acromegaly Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acromegaly Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acromegaly Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acromegaly Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acromegaly Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acromegaly Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acromegaly Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Acromegaly Therapeutics Introduction
11.1.4 Novartis Revenue in Acromegaly Therapeutics Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 IPSEN
11.2.1 IPSEN Company Details
11.2.2 IPSEN Business Overview
11.2.3 IPSEN Acromegaly Therapeutics Introduction
11.2.4 IPSEN Revenue in Acromegaly Therapeutics Business (2016-2021)
11.2.5 IPSEN Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Acromegaly Therapeutics Introduction
11.3.4 Pfizer Revenue in Acromegaly Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acromegaly Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Octreotide
Table 3. Key Players of Pasireotide
Table 4. Key Players of Lanreotide
Table 5. Key Players of Pegvisomant
Table 6. Global Acromegaly Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acromegaly Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acromegaly Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acromegaly Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Acromegaly Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acromegaly Therapeutics Market Share by Regions (2022-2027)
Table 12. Acromegaly Therapeutics Market Trends
Table 13. Acromegaly Therapeutics Market Drivers
Table 14. Acromegaly Therapeutics Market Challenges
Table 15. Acromegaly Therapeutics Market Restraints
Table 16. Global Acromegaly Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acromegaly Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Acromegaly Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly Therapeutics as of 2020)
Table 19. Ranking of Global Top Acromegaly Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acromegaly Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acromegaly Therapeutics Product Solution and Service
Table 23. Date of Enter into Acromegaly Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acromegaly Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acromegaly Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Acromegaly Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acromegaly Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acromegaly Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acromegaly Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Acromegaly Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acromegaly Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acromegaly Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acromegaly Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acromegaly Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acromegaly Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acromegaly Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acromegaly Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acromegaly Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acromegaly Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acromegaly Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acromegaly Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acromegaly Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acromegaly Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acromegaly Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acromegaly Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acromegaly Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acromegaly Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acromegaly Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acromegaly Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acromegaly Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acromegaly Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acromegaly Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acromegaly Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acromegaly Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acromegaly Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acromegaly Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acromegaly Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acromegaly Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acromegaly Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acromegaly Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acromegaly Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Acromegaly Therapeutics Product
Table 66. Novartis Revenue in Acromegaly Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. IPSEN Company Details
Table 69. IPSEN Business Overview
Table 70. IPSEN Acromegaly Therapeutics Product
Table 71. IPSEN Revenue in Acromegaly Therapeutics Business (2016-2021) & (US$ Million)
Table 72. IPSEN Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Acromegaly Therapeutics Product
Table 76. Pfizer Revenue in Acromegaly Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acromegaly Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Octreotide Features
Figure 3. Pasireotide Features
Figure 4. Lanreotide Features
Figure 5. Pegvisomant Features
Figure 6. Global Acromegaly Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Acromegaly Therapeutics Report Years Considered
Figure 10. Global Acromegaly Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acromegaly Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acromegaly Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Acromegaly Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Acromegaly Therapeutics Market Share by Players in 2020
Figure 15. Global Top Acromegaly Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acromegaly Therapeutics Revenue in 2020
Figure 17. Global Acromegaly Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Acromegaly Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acromegaly Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Acromegaly Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Acromegaly Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acromegaly Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Acromegaly Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Acromegaly Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acromegaly Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acromegaly Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acromegaly Therapeutics Market Share by Region (2016-2027)
Figure 39. China Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acromegaly Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Acromegaly Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Acromegaly Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acromegaly Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acromegaly Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acromegaly Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acromegaly Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Acromegaly Therapeutics Business (2016-2021)
Figure 59. IPSEN Revenue Growth Rate in Acromegaly Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Acromegaly Therapeutics Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

---